Information:
Error:
ID
44427
Description
A Study of the Safety of Individualized Combination Therapy With Copegus (Ribavirin) and Pegasys (Peginterferon Alfa-2a) in Patients With Chronic Hepatitis C (MASTER); ODM derived from: https://clinicaltrials.gov/show/NCT01296971
Link
https://clinicaltrials.gov/show/NCT01296971
Keywords
Versions (2)
- 2/11/20 2/11/20 -
- 9/20/21 9/20/21 -
Copyright Holder
See clinicaltrials.gov
Uploaded on
September 20, 2021
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Hepatitis C, Chronic NCT01296971
Eligibility Hepatitis C, Chronic NCT01296971
- StudyEvent: Eligibility
Similar models
Eligibility Hepatitis C, Chronic NCT01296971
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Adult | Age
Item
adult patients, >/= 18 years of age
boolean
C0001675 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
C0001779 (UMLS CUI [2])
Hepatitis C, Chronic
Item
chronic hepatitis c
boolean
C0524910 (UMLS CUI [1])
Hepatitis C virus RNA assay Serum
Item
measurable serum hvc rna levels
boolean
C1272251 (UMLS CUI [1,1])
C0229671 (UMLS CUI [1,2])
C0229671 (UMLS CUI [1,2])
Compensated liver disease Child-Pugh Classification
Item
compensated liver disease (child-pugh class a)
boolean
C3839044 (UMLS CUI [1,1])
C4050412 (UMLS CUI [1,2])
C4050412 (UMLS CUI [1,2])
Standard therapy Absent | PEGINTERFERON | Therapy non-responder | Recurrent disease
Item
treatment-naive for standard or pegylated interferons, or non-responder or relapsing
boolean
C2936643 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0982327 (UMLS CUI [2])
C0919875 (UMLS CUI [3])
C0277556 (UMLS CUI [4])
C0332197 (UMLS CUI [1,2])
C0982327 (UMLS CUI [2])
C0919875 (UMLS CUI [3])
C0277556 (UMLS CUI [4])
Hepatitis A | Hepatitis B
Item
concomitant hepatitis a or b
boolean
C0019159 (UMLS CUI [1])
C0019163 (UMLS CUI [2])
C0019163 (UMLS CUI [2])
Chronic liver disease | Etiology Except Hepatitis C virus
Item
history of chronic liver disease not caused by hepatitis c virus
boolean
C0341439 (UMLS CUI [1])
C0015127 (UMLS CUI [2,1])
C0332300 (UMLS CUI [2,2])
C0220847 (UMLS CUI [2,3])
C0015127 (UMLS CUI [2,1])
C0332300 (UMLS CUI [2,2])
C0220847 (UMLS CUI [2,3])
Liver carcinoma
Item
hepatocellular carcinoma
boolean
C2239176 (UMLS CUI [1])
Bleeding esophageal varices | Signs Bleeding esophageal varices | Condition Indication of Decompensated liver disease
Item
history or signs of esophageal varices haemorrhage or other conditions indicative of decompensated liver disease
boolean
C0155789 (UMLS CUI [1])
C0311392 (UMLS CUI [2,1])
C0155789 (UMLS CUI [2,2])
C0348080 (UMLS CUI [3,1])
C0392360 (UMLS CUI [3,2])
C4075847 (UMLS CUI [3,3])
C0311392 (UMLS CUI [2,1])
C0155789 (UMLS CUI [2,2])
C0348080 (UMLS CUI [3,1])
C0392360 (UMLS CUI [3,2])
C4075847 (UMLS CUI [3,3])
Antineoplastic Agents Systemic | Immunomodulatory agents Systemic | Steroid therapy | Therapeutic radiology procedure
Item
treatment with any systemic anti-tumor or immunomodulatory agent (including steroids at doses exceeding physiological ones, and radiotherapy) within 6 months prior to first dose of study drug
boolean
C0003392 (UMLS CUI [1,1])
C0205373 (UMLS CUI [1,2])
C0005525 (UMLS CUI [2,1])
C0205373 (UMLS CUI [2,2])
C0149783 (UMLS CUI [3])
C1522449 (UMLS CUI [4])
C0205373 (UMLS CUI [1,2])
C0005525 (UMLS CUI [2,1])
C0205373 (UMLS CUI [2,2])
C0149783 (UMLS CUI [3])
C1522449 (UMLS CUI [4])
Pregnancy | Breast Feeding | Gender Partner Pregnancy
Item
pregnant or lactating women, or men whose partners are pregnant
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0079399 (UMLS CUI [3,1])
C0682323 (UMLS CUI [3,2])
C0032961 (UMLS CUI [3,3])
C0006147 (UMLS CUI [2])
C0079399 (UMLS CUI [3,1])
C0682323 (UMLS CUI [3,2])
C0032961 (UMLS CUI [3,3])